US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immuneering Corp

2.13

+0.08003.90%

Post-market: 2.290.1589+7.46%19:54 EDT

Volume:748.05K

Turnover:1.65M

Market Cap:76.65M

PE:-1.09

High:2.41

Open:2.02

Low:2.01

Close:2.05

Loading ...

Overview Company News Filings

Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Johnson & Johnson (JNJ)

3 Penny Stocks to Watch Now, 1/9/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sana Biotechnology (SANA), Immuneering (IMRX) and Johnson & Johnson (JNJ)

Sector Update: Health Care Stocks Rise in Afternoon Trading

MT Newswires Live

Immuneering Price Target Maintained With a $15.00/Share by Needham

Immuneering Shares up 50% After Positive Mid-Stage Trial Data for Pancreatic Cancer Therapy

THOMSON REUTERS

Immuneering Says New Phase 2a Pancreatic Cancer Trial Data Show Better Response, Disease Control Rates

MT Newswires Live

BUZZ-Immuneering soars on positive trial data for pancreatic cancer therapy

Immuneering Shares up 51.7% Premarket After Positive Mid-Stage Trial Data for Pancreatic Cancer Therapy

THOMSON REUTERS

BRIEF-Immuneering Announces Positive Data Update From Three Pancreatic Cancer Arms Of Ongoing Phase 2A Trial Of IMM-1-104

Immuneering announce data update from Phase 2a trial of IMM-1-104

Immuneering Corp - Imm-1-104 With Folfirinox Shows 100% Lesion Reduction in Pancreatic Cancer

THOMSON REUTERS

Immuneering Corp - Imm-1-104 Shows 43% Orr and 86% Dcr in Pancreatic Cancer

THOMSON REUTERS

Immuneering Corp - Further Imm-1-104 Phase 2a Data Expected in 2Q’25

THOMSON REUTERS

Immuneering Announces Positive Data Update From Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of Imm-1-104; Plans to Expand Trial With Additional Arms

THOMSON REUTERS

Immuneering Announces Positive Data Update from Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of IMM-1-104; Plans to Expand Trial with Additional Arms

Aadi Bioscience Leads 3 Promising US Penny Stocks

Simply Wall St.

Immuneering launches Pancreatic Cancer Advisory Board

Immuneering Launches Pancreatic Cancer Advisory Board

Immuneering to present data from Phase 2a trial of IMM-1-104 in early January

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IMRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","market":"US","secType":"STK","nameCN":"Immuneering Corp","latestPrice":2.13,"timestamp":1749240000000,"preClose":2.05,"halted":0,"volume":748050,"hourTrading":{"tag":"盘后","latestPrice":2.2889,"preClose":2.13,"latestTime":"19:54 EDT","volume":11576,"amount":24727.3506,"timestamp":1749254054027},"delay":0,"floatShares":27332857,"shares":35985702,"eps":-1.959777,"marketStatus":"Market Closed","change":0.08,"latestTime":"06-06 16:00:00 EDT","open":2.02,"high":2.405,"low":2.0137,"amount":1654836.65883,"amplitude":0.190878,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.959777,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":2.05,"preHourTrading":{"tag":"盘前","latestPrice":2,"preClose":2.05,"latestTime":"09:26 EDT","volume":3537,"amount":7146.2697525,"timestamp":1749216372933},"postHourTrading":{"tag":"盘后","latestPrice":2.2889,"preClose":2.13,"latestTime":"19:54 EDT","volume":11576,"amount":24727.3506,"timestamp":1749254054027},"volumeRatio":2.6964860805174347},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","floatShares":27332857,"roa":"-57.90%","roe":"-102.48%","lyrEps":-2.035804,"volumeRatio":2.6964860805174347,"shares":35985702,"dividePrice":0,"high":2.405,"amplitude":0.190878,"preClose":2.05,"low":2.0137,"week52Low":1,"pbRate":"1.83","psRate":"168460.54","week52High":3.83,"institutionHeld":0,"latestPrice":2.13,"eps":-1.959777,"divideRate":0,"volume":748050,"delay":0,"ttmEps":-1.959777,"open":2.02,"prevYearClose":2.2,"prevWeekClose":1.71,"prevMonthClose":1.71,"prevQuarterClose":1.52,"fiveDayClose":1.71,"twentyDayClose":1.19,"sixtyDayClose":1.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2502369363","title":"Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502369363","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502369363?lang=en_us&edition=fundamental","pubTime":"2025-01-12 18:40","pubTimestamp":1736678417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immuneering (IMRX – Research Report) and Johnson & J...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-johnson-johnson-jnj?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-johnson-johnson-jnj?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZLL34.SGD","JNJ","LU1718418525.SGD","LU2347655156.SGD","BK4532","BK4592","LU0882574055.USD","LU1732799900.SGD","IE00BDGV0183.EUR","BK4563","IE00BJJMRZ35.SGD","LU1585245621.USD","LU1778281490.HKD","LU2468319806.SGD","LU0058720904.USD","IMRX","LU1196500208.SGD","BK4137","LU1066051498.USD","IE00BVYPNV92.GBP","BK4585","IE00BVYPNW00.USD","LU0122379950.USD","LU0320765646.SGD","LU2133065610.SGD","LU1929549753.HKD","HCSG","IE00B2B36J28.USD","BK4504","IE00B42XCP33.USD","LU1059921491.USD","IE00B19Z3581.USD","LU1935042991.SGD","BK4588","LU1066051225.USD","LU2602419157.SGD","IE00BGHQF631.EUR","LU1162221912.USD","IE0002270589.USD","IE0034235303.USD","LU1244550577.SGD","BK4559","LU0466842654.USD","LU1914381329.SGD","LU1221951129.SGD","LU1066053197.SGD","LU0912757837.SGD","LU1894683348.USD","LU1261432733.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"2502099983","title":"3 Penny Stocks to Watch Now, 1/9/25","url":"https://stock-news.laohu8.com/highlight/detail?id=2502099983","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502099983?lang=en_us&edition=fundamental","pubTime":"2025-01-09 17:42","pubTimestamp":1736415747,"startTime":"0","endTime":"0","summary":"Hoth Therapeutics, XTI Aerospace, and Immuneering are the 3 Penny Stocks to watch on January 9, 2025, based on TipRanks’ Penny Stock...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-1-9-25?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-1-9-25?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4563","IMRX","BK4139"],"gpt_icon":0},{"id":"2501742689","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sana Biotechnology (SANA), Immuneering (IMRX) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501742689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501742689?lang=en_us&edition=fundamental","pubTime":"2025-01-08 18:50","pubTimestamp":1736333450,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sana Biotechnology (SANA – Research Report), Immun...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sana-biotechnology-sana-immuneering-imrx-and-johnson-johnson-jnj?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sana-biotechnology-sana-immuneering-imrx-and-johnson-johnson-jnj?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1244550221.USD","LU1732799900.SGD","IE00BDGV0183.EUR","BK4568","SG9999002224.SGD","LU1196500208.SGD","LU1267930813.SGD","LU1023059063.AUD","LU1066051498.USD","LU1221951129.SGD","LU1221951046.USD","IE0002141913.USD","LU2468319806.SGD","LU2602419157.SGD","LU0058720904.USD","IMRX","LU0466842654.USD","LU1929549753.HKD","LU0640476718.USD","LU1778281490.HKD","HCSG","LU1585245621.USD","LU1066053197.SGD","LU0203345920.USD","SANA","LU1914381329.SGD","LU0912757837.SGD","LU0114720955.EUR","BK4532","JNJ","BK4007","LU0889566641.SGD","BK4504","LU1066051225.USD","LU0792757196.USD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","LU1280957306.USD","BK4585","LU1935042991.SGD","IE00B7SZLL34.SGD","LU1074936037.SGD","LU1261432733.SGD","LU1674673428.USD","LU0122379950.USD","LU0234570918.USD","LU1066051811.HKD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU1732800096.USD"],"gpt_icon":0},{"id":"2501362947","title":"Sector Update: Health Care Stocks Rise in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2501362947","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501362947?lang=en_us&edition=fundamental","pubTime":"2025-01-08 02:58","pubTimestamp":1736276322,"startTime":"0","endTime":"0","summary":"Health care stocks rose Tuesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.7%.The iShares Biotechnology ETF (IBB) climbed 1.2%.In corporate n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1791710400.SGD","LU0690374615.EUR","LU0528227936.USD","LU2404859667.USD","LU2468319806.SGD","BK4139","GB00B4LPDJ14.GBP","LU0390134368.USD","LU2404859741.USD","BK4585","GB00B4QBRK32.GBP","IBB","LU2089984988.USD","BK4504","BK4588","BK4007","LU2362540622.SGD","HOTH","LU0690374961.EUR","BK4082","NARI","LU0882574055.USD","SYK","BK4539","LU2362541273.HKD","LU2362541513.USD","BK4581","XLV","BK4566","LU0114720955.EUR","BK4563","LU1983299246.USD","IMRX","LU1791710582.SGD"],"gpt_icon":1},{"id":"2501817237","title":"Immuneering Price Target Maintained With a $15.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2501817237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501817237?lang=en_us&edition=fundamental","pubTime":"2025-01-08 00:23","pubTimestamp":1736266980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 07, 2025 11:23 ET (16:23 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX"],"gpt_icon":0},{"id":"2501207452","title":"Immuneering Shares up 50% After Positive Mid-Stage Trial Data for Pancreatic Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2501207452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501207452?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:31","pubTimestamp":1736260269,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nFWN3O31HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4139","BK4563","BK4539"],"gpt_icon":0},{"id":"2501743204","title":"Immuneering Says New Phase 2a Pancreatic Cancer Trial Data Show Better Response, Disease Control Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2501743204","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501743204?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:00","pubTimestamp":1736258404,"startTime":"0","endTime":"0","summary":"Immuneering  said Tuesday that new data from an ongoing phase 2a trial of its lead candidate IMM-1-104 in pancreatic cancer showed better overall response and disease control rates.The updated results for IMM-1-104 combined with modified gemcitabine/nab-paclitaxel showed pancreatic cancer patients achieved an overall response rate of 43% and a disease control rate of 86%, compared with benchmarks of 23% and 48%, respectively, according to Immuneering Chief Executive Ben Zeskind.In another combination arm with modified Folfirinox, all evaluable patients experienced target lesion shrinkage, including a 100% reduction, the company said.As a monotherapy in second-line patients, IMM-1-104 demonstrated a partial response with 67% reduction in target lesions, according to Immuneering.The drug was well-tolerated in both combination and monotherapy arms, the company said, adding it plans to expand the phase 2a trial in 2025 to include three new combination arms.Shares of Immuneering surged past","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMRX","BK4563","BK4539","BK4139"],"gpt_icon":1},{"id":"2501205380","title":"BUZZ-Immuneering soars on positive trial data for pancreatic cancer therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2501205380","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501205380?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:53","pubTimestamp":1736254414,"startTime":"0","endTime":"0","summary":"** Shares of therapy developer Immuneering    rise 101.7% to $4.76 premarket   ** Co says its therapy, IMM-1-104, showed an overall response rate of 43% in combination with gemcitabine during a mid-stage trial for patients with pancreatic cancer    ** IMRX will expand the trial to include three combination treatment arms this year in addition to the existing three arms   ** Co says it expects further trial data in Q2 2025   ** Up to last close, stock down 64.8% in the previous 12 months   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"BUZZ-Immuneering soars on positive trial data for pancreatic cancer therapy","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","BK4539","IMRX"],"gpt_icon":0},{"id":"2501258208","title":"Immuneering Shares up 51.7% Premarket After Positive Mid-Stage Trial Data for Pancreatic Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2501258208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501258208?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:27","pubTimestamp":1736252853,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nFWN3O30NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","IMRX","BK4539","BK4139"],"gpt_icon":0},{"id":"2501720885","title":"BRIEF-Immuneering Announces Positive Data Update From Three Pancreatic Cancer Arms Of Ongoing Phase 2A Trial Of IMM-1-104","url":"https://stock-news.laohu8.com/highlight/detail?id=2501720885","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501720885?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:16","pubTimestamp":1736252185,"startTime":"0","endTime":"0","summary":"BRIEF-Immuneering Announces Positive Data Update From Three Pancreatic Cancer Arms Of Ongoing Phase 2A Trial Of IMM-1-104Jan 7 (Reuters) - Immuneering Corp IMRX.O:IMMUNEERING ANNOUNCES POSITIVE DATA U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA6XLNHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMRX","BK4563","BK4539"],"gpt_icon":0},{"id":"2501208801","title":"Immuneering announce data update from Phase 2a trial of IMM-1-104","url":"https://stock-news.laohu8.com/highlight/detail?id=2501208801","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501208801?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:11","pubTimestamp":1736251918,"startTime":"0","endTime":"0","summary":"Immuneering (IMRX) announced a positive data update from three pancreatic cancer arms of its ongoing Phase 2a trial of lead program IMM-1-104, as w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immuneering-announce-data-update-from-phase-2a-trial-of-imm-1-104?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immuneering-announce-data-update-from-phase-2a-trial-of-imm-1-104?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4563","IMRX","BK4539"],"gpt_icon":0},{"id":"2501827054","title":"Immuneering Corp - Imm-1-104 With Folfirinox Shows 100% Lesion Reduction in Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2501827054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501827054?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA6XLNHS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4563","IMRX","BK4139"],"gpt_icon":0},{"id":"2501705272","title":"Immuneering Corp - Imm-1-104 Shows 43% Orr and 86% Dcr in Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2501705272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501705272?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA6XLNHS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMRX","BK4563","BK4539"],"gpt_icon":0},{"id":"2501270557","title":"Immuneering Corp - Further Imm-1-104 Phase 2a Data Expected in 2Q’25","url":"https://stock-news.laohu8.com/highlight/detail?id=2501270557","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501270557?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA6XLNHS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4563","IMRX","BK4139"],"gpt_icon":0},{"id":"2501270549","title":"Immuneering Announces Positive Data Update From Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of Imm-1-104; Plans to Expand Trial With Additional Arms","url":"https://stock-news.laohu8.com/highlight/detail?id=2501270549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501270549?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA6XLNHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","BK4539","IMRX"],"gpt_icon":0},{"id":"2501270134","title":"Immuneering Announces Positive Data Update from Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of IMM-1-104; Plans to Expand Trial with Additional Arms","url":"https://stock-news.laohu8.com/highlight/detail?id=2501270134","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501270134?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251200,"startTime":"0","endTime":"0","summary":"- Updated data for IMM-1-104 in combination with modified gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic cancer patients show favorable overall response rate (ORR = 43%) and disease contro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/07/3005238/0/en/Immuneering-Announces-Positive-Data-Update-from-Three-Pancreatic-Cancer-Arms-of-Ongoing-Phase-2a-Trial-of-IMM-1-104-Plans-to-Expand-Trial-with-Additional-Arms.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PR","BK4139","BK4161","BK4539","CR","BK4213","IMRX","BK4563"],"gpt_icon":0},{"id":"2493279179","title":"Aadi Bioscience Leads 3 Promising US Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2493279179","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493279179?lang=en_us&edition=fundamental","pubTime":"2024-12-23 08:09","pubTimestamp":1734912591,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates a challenging week marked by encouraging inflation data yet overall losses, investors are exploring diverse opportunities to mitigate risk and capitalize on potential gains. Penny stocks, often associated with smaller or newer companies, continue to attract attention due to their potential for significant returns when backed by strong financial health. Despite being considered a niche area of investment today, these stocks can offer intriguing opportunities for those willing to explore beyond traditional large-cap options.Overview: Aadi Bioscience, Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, with a market cap of $83.55 million.Get an in-depth perspective on Aadi Bioscience's performance by reading our balance sheet health report here.Understand Aadi Bioscience's earnings outlook by examining our growth report.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NPWPwaqd_YNMPuUbekamwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/17286ad821a1799fbe520d67c5c5f1ea","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NPWPwaqd_YNMPuUbekamwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/17286ad821a1799fbe520d67c5c5f1ea"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aadi-bioscience-leads-3-promising-000951326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QD","BABB","AADI","BK4503","SB","BK4139","BK4021","IMRX","BK4539","BK4563","BK4166","BK4209"],"gpt_icon":0},{"id":"2492205601","title":"Immuneering launches Pancreatic Cancer Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2492205601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492205601?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:15","pubTimestamp":1734614115,"startTime":"0","endTime":"0","summary":"Immuneering (IMRX) Corporation announced the formation of its Pancreatic Cancer Advisory Board. The Company’s Pancreatic Cancer Advisory Board incl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immuneering-launches-pancreatic-cancer-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immuneering-launches-pancreatic-cancer-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","IMRX","BK4139","BK4563"],"gpt_icon":0},{"id":"2492465127","title":"Immuneering Launches Pancreatic Cancer Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2492465127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492465127?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:00","pubTimestamp":1734613200,"startTime":"0","endTime":"0","summary":"- Establishment reflects the clinical progress of IMM-1-104 and its promise in pancreatic cancer - - Follows recent Orphan Drug designation in pancreatic cancer and Fast Track designations in first- a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/19/2999777/0/en/Immuneering-Launches-Pancreatic-Cancer-Advisory-Board.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IMRX","BK4539","BK4139"],"gpt_icon":0},{"id":"2492495474","title":"Immuneering to present data from Phase 2a trial of IMM-1-104 in early January","url":"https://stock-news.laohu8.com/highlight/detail?id=2492495474","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492495474?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:11","pubTimestamp":1734441079,"startTime":"0","endTime":"0","summary":"Immuneering (IMRX) will hold a virtual Investor Event in early January 2025 to discuss data from its ongoing Phase 2a trial of IMM-1-104. Specifica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immuneering-to-present-data-from-phase-2a-trial-of-imm-1-104-in-early-january?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immuneering-to-present-data-from-phase-2a-trial-of-imm-1-104-in-early-january?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IMRX","BK4539","BK4563"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-02-08","symbol":"IMRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1644296400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-09-09","symbol":"IMRX","fiscalQuarterEnding":"2021/06","expectedEps":-1.78,"name":null,"time":"","type":"earning","dateTimestamp":1631160000000,"reportTimeType":"","actualEps":-1.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1734062400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMRX","date":"2025-06-05","current":-1.141758,"percent":0.755914,"low":-38.293729,"twenty":-6.739485,"median":-3.678927,"eighty":-1.026662,"high":-0.544763,"avg":-6.226663,"sd":8.126625,"marketCap":70531975},"quantilePoints":[{"date":"2021-07-30","current":-21.376918,"twenty":-19.48836,"median":-18.229322,"eighty":-11.994698,"marketCap":429009721},{"date":"2021-08-06","current":-34.307584,"twenty":-29.575252,"median":-21.376918,"eighty":-18.229322,"marketCap":688513044},{"date":"2021-08-13","current":-34.781547,"twenty":-35.214189,"median":-30.108764,"eighty":-19.687668,"marketCap":698024914},{"date":"2021-08-20","current":-36.981218,"twenty":-36.655521,"median":-34.307584,"eighty":-21.09011,"marketCap":742169746},{"date":"2021-08-27","current":-32.375276,"twenty":-36.475658,"median":-34.52026,"eighty":-22.529012,"marketCap":649733882},{"date":"2021-09-03","current":-34.404807,"twenty":-36.171837,"median":-34.307584,"eighty":-25.783553,"marketCap":690464197},{"date":"2021-09-10","current":-22.010777,"twenty":-35.957946,"median":-32.776321,"eighty":-24.276106,"marketCap":538214828},{"date":"2021-09-17","current":-30.210454,"twenty":-35.824264,"median":-31.84055,"eighty":-25.184572,"marketCap":738716062},{"date":"2021-09-24","current":-29.160302,"twenty":-35.381899,"median":-31.06967,"eighty":-26.168957,"marketCap":713037379},{"date":"2021-10-01","current":-30.655974,"twenty":-34.823563,"median":-31.016632,"eighty":-26.847844,"marketCap":749610049},{"date":"2021-10-08","current":-29.393669,"twenty":-34.79613,"median":-30.963594,"eighty":-27.123376,"marketCap":718743753},{"date":"2021-10-15","current":-26.370502,"twenty":-34.757241,"median":-30.737841,"eighty":-25.579175,"marketCap":644820271},{"date":"2021-10-22","current":-27.420655,"twenty":-34.594392,"median":-30.019518,"eighty":-25.579175,"marketCap":670498954},{"date":"2021-10-29","current":-28.746605,"twenty":-34.370779,"median":-29.565885,"eighty":-25.859215,"marketCap":702921534},{"date":"2021-11-05","current":-31.674304,"twenty":-34.314876,"median":-29.74372,"eighty":-26.166836,"marketCap":774510591},{"date":"2021-11-12","current":-25.289652,"twenty":-34.283278,"median":-29.565885,"eighty":-26.166836,"marketCap":722963518},{"date":"2021-11-19","current":-22.558333,"twenty":-33.710006,"median":-28.972469,"eighty":-25.187144,"marketCap":644882421},{"date":"2021-11-26","current":-20.453131,"twenty":-32.879093,"median":-28.778428,"eighty":-24.841544,"marketCap":584700312},{"date":"2021-12-03","current":-17.576626,"twenty":-32.696112,"median":-28.497326,"eighty":-23.741458,"marketCap":502468724},{"date":"2021-12-10","current":-19.636457,"twenty":-32.324185,"median":-28.163187,"eighty":-22.296998,"marketCap":561353804},{"date":"2021-12-17","current":-19.309788,"twenty":-32.100427,"median":-27.505516,"eighty":-21.262189,"marketCap":552015201},{"date":"2021-12-23","current":-18.874241,"twenty":-32.022843,"median":-27.430931,"eighty":-20.552946,"marketCap":539564079},{"date":"2021-12-31","current":-14.887633,"twenty":-31.674304,"median":-27.177075,"eighty":-20.40776,"marketCap":425597617},{"date":"2022-01-07","current":-14.243147,"twenty":-31.658256,"median":-26.71902,"eighty":-19.482197,"marketCap":407173478},{"date":"2022-01-14","current":-11.969031,"twenty":-31.51519,"median":-26.42354,"eighty":-19.028489,"marketCap":342162587},{"date":"2022-01-21","current":-11.103578,"twenty":-31.481245,"median":-26.031059,"eighty":-18.640116,"marketCap":317421599},{"date":"2022-01-28","current":-9.206947,"twenty":-31.447301,"median":-25.379254,"eighty":-18.098783,"marketCap":263201990},{"date":"2022-02-04","current":-9.022808,"twenty":-31.303678,"median":-25.09002,"eighty":-15.312994,"marketCap":257937950},{"date":"2022-02-11","current":-8.746599,"twenty":-31.202956,"median":-24.614944,"eighty":-14.27445,"marketCap":250041890},{"date":"2022-02-18","current":-7.669387,"twenty":-31.093007,"median":-23.973184,"eighty":-13.003892,"marketCap":219247257},{"date":"2022-02-25","current":-7.227453,"twenty":-31.006024,"median":-23.297074,"eighty":-12.195522,"marketCap":206613562},{"date":"2022-03-04","current":-6.104206,"twenty":-30.912677,"median":-22.394998,"eighty":-11.324544,"marketCap":174502919},{"date":"2022-03-11","current":-5.104662,"twenty":-30.843317,"median":-21.805179,"eighty":-10.260222,"marketCap":171188670},{"date":"2022-03-18","current":-5.505799,"twenty":-30.766019,"median":-21.218553,"eighty":-9.206947,"marketCap":184641093},{"date":"2022-03-25","current":-5.702435,"twenty":-30.685675,"median":-20.552946,"eighty":-9.004394,"marketCap":191235417},{"date":"2022-04-01","current":-5.851878,"twenty":-30.388662,"median":-20.434983,"eighty":-8.728185,"marketCap":196247104},{"date":"2022-04-08","current":-5.560857,"twenty":-30.095892,"median":-19.881459,"eighty":-7.906926,"marketCap":186487503},{"date":"2022-04-14","current":-5.026008,"twenty":-29.909199,"median":-19.636457,"eighty":-7.155639,"marketCap":168550940},{"date":"2022-04-22","current":-4.632737,"twenty":-29.741472,"median":-19.332473,"eighty":-6.57376,"marketCap":155362291},{"date":"2022-04-29","current":-3.909117,"twenty":-29.600328,"median":-19.028489,"eighty":-6.236786,"marketCap":131095176},{"date":"2022-05-06","current":-3.863096,"twenty":-29.300322,"median":-18.77442,"eighty":-6.076585,"marketCap":129551818},{"date":"2022-05-13","current":-3.301241,"twenty":-29.085169,"median":-18.248113,"eighty":-5.773224,"marketCap":132718053},{"date":"2022-05-20","current":-2.868076,"twenty":-28.958498,"median":-17.902974,"eighty":-5.560857,"marketCap":115303756},{"date":"2022-05-27","current":-3.032154,"twenty":-28.873896,"median":-15.642603,"eighty":-5.43973,"marketCap":121900081},{"date":"2022-06-03","current":-3.117474,"twenty":-28.772063,"median":-15.136221,"eighty":-5.357929,"marketCap":125330170},{"date":"2022-06-10","current":-3.248736,"twenty":-28.702053,"median":-14.560786,"eighty":-5.169159,"marketCap":130607230},{"date":"2022-06-17","current":-3.019028,"twenty":-28.513237,"median":-14.243147,"eighty":-5.057469,"marketCap":121372375},{"date":"2022-06-24","current":-2.966523,"twenty":-28.470807,"median":-13.018623,"eighty":-4.797911,"marketCap":119261551},{"date":"2022-07-01","current":-3.281552,"twenty":-28.322301,"median":-12.535258,"eighty":-4.516125,"marketCap":131926495},{"date":"2022-07-08","current":-4.77794,"twenty":-28.19501,"median":-11.72965,"eighty":-4.342773,"marketCap":192084976},{"date":"2022-07-15","current":-4.764813,"twenty":-27.798285,"median":-11.342958,"eighty":-4.376588,"marketCap":191557270},{"date":"2022-07-22","current":-4.679493,"twenty":-27.596741,"median":-11.177233,"eighty":-4.47804,"marketCap":188127181},{"date":"2022-07-29","current":-4.279144,"twenty":-27.467328,"median":-9.768571,"eighty":-4.342843,"marketCap":172032149},{"date":"2022-08-05","current":-4.200386,"twenty":-27.441339,"median":-9.354258,"eighty":-4.248161,"marketCap":168865913},{"date":"2022-08-12","current":-3.583967,"twenty":-27.424765,"median":-9.206947,"eighty":-4.220076,"marketCap":156770256},{"date":"2022-08-19","current":-4.036488,"twenty":-27.284877,"median":-8.99979,"eighty":-4.217662,"marketCap":176564480},{"date":"2022-08-26","current":-3.638269,"twenty":-27.191847,"median":-8.820255,"eighty":-4.112624,"marketCap":159145562},{"date":"2022-09-02","current":-4.489009,"twenty":-26.964607,"median":-8.663737,"eighty":-4.062597,"marketCap":196358704},{"date":"2022-09-09","current":-5.351815,"twenty":-26.847844,"median":-8.102113,"eighty":-4.089364,"marketCap":234099692},{"date":"2022-09-16","current":-7.409278,"twenty":-26.701741,"median":-7.540489,"eighty":-4.110182,"marketCap":324097431},{"date":"2022-09-23","current":-6.184454,"twenty":-26.518292,"median":-7.478664,"eighty":-4.129108,"marketCap":270521064},{"date":"2022-09-30","current":-8.640135,"twenty":-26.430952,"median":-7.511849,"eighty":-4.171405,"marketCap":377937721},{"date":"2022-10-07","current":-7.753194,"twenty":-26.391717,"median":-7.604938,"eighty":-4.197576,"marketCap":339141042},{"date":"2022-10-14","current":-7.759227,"twenty":-26.166836,"median":-7.710958,"eighty":-4.204957,"marketCap":339404965},{"date":"2022-10-21","current":-7.825597,"twenty":-25.859215,"median":-7.75621,"eighty":-4.215247,"marketCap":342308118},{"date":"2022-10-28","current":-8.145379,"twenty":-25.579175,"median":-7.831631,"eighty":-4.220076,"marketCap":356296036},{"date":"2022-11-04","current":-6.226689,"twenty":-25.361334,"median":-7.837664,"eighty":-4.222148,"marketCap":272368525},{"date":"2022-11-11","current":-4.159708,"twenty":-25.187144,"median":-7.759227,"eighty":-4.222148,"marketCap":199883821},{"date":"2022-11-18","current":-3.846494,"twenty":-25.101534,"median":-7.732076,"eighty":-4.197576,"marketCap":184833124},{"date":"2022-11-25","current":-3.610209,"twenty":-25.039205,"median":-7.656988,"eighty":-4.124428,"marketCap":173479089},{"date":"2022-12-02","current":-3.25853,"twenty":-24.902263,"median":-7.535984,"eighty":-4.049542,"marketCap":156580060},{"date":"2022-12-09","current":-2.846405,"twenty":-24.654192,"median":-7.415311,"eighty":-3.946191,"marketCap":136776511},{"date":"2022-12-16","current":-2.302401,"twenty":-24.266189,"median":-7.240336,"eighty":-3.838309,"marketCap":110635827},{"date":"2022-12-23","current":-2.401311,"twenty":-24.011725,"median":-7.167608,"eighty":-3.788803,"marketCap":115388678},{"date":"2022-12-30","current":-2.665071,"twenty":-23.915253,"median":-6.893039,"eighty":-3.65307,"marketCap":128062950},{"date":"2023-01-06","current":-2.165026,"twenty":-23.683527,"median":-6.748692,"eighty":-3.620168,"marketCap":104034644},{"date":"2023-01-13","current":-2.434281,"twenty":-23.297074,"median":-6.444863,"eighty":-3.571744,"marketCap":116972962},{"date":"2023-01-20","current":-2.384826,"twenty":-23.091187,"median":-6.389597,"eighty":-3.539873,"marketCap":114596536},{"date":"2023-01-27","current":-2.445271,"twenty":-22.654609,"median":-6.277203,"eighty":-3.410189,"marketCap":117501057},{"date":"2023-02-03","current":-2.181511,"twenty":-22.296998,"median":-6.214689,"eighty":-3.365467,"marketCap":104826786},{"date":"2023-02-10","current":-2.077107,"twenty":-22.054954,"median":-6.163676,"eighty":-3.32093,"marketCap":99809886},{"date":"2023-02-17","current":-2.522201,"twenty":-21.846299,"median":-6.058171,"eighty":-3.281552,"marketCap":121197719},{"date":"2023-02-24","current":-2.577151,"twenty":-21.548222,"median":-5.985345,"eighty":-3.232985,"marketCap":123838193},{"date":"2023-03-03","current":-2.79695,"twenty":-21.290871,"median":-5.847945,"eighty":-3.116748,"marketCap":134400085},{"date":"2023-03-10","current":-3.940801,"twenty":-21.215562,"median":-5.7103,"eighty":-3.10326,"marketCap":199063900},{"date":"2023-03-17","current":-4.223408,"twenty":-20.877378,"median":-5.560857,"eighty":-3.116748,"marketCap":213339399},{"date":"2023-03-24","current":-5.427105,"twenty":-20.595727,"median":-5.505799,"eighty":-3.117474,"marketCap":274142450},{"date":"2023-03-31","current":-5.081696,"twenty":-20.542057,"median":-5.445473,"eighty":-3.164729,"marketCap":256694618},{"date":"2023-04-06","current":-4.375178,"twenty":-20.502131,"median":-5.427125,"eighty":-3.201482,"marketCap":221005871},{"date":"2023-04-14","current":-6.463332,"twenty":-20.438612,"median":-5.432339,"eighty":-3.225109,"marketCap":326485946},{"date":"2023-04-21","current":-6.832312,"twenty":-20.413204,"median":-5.498193,"eighty":-3.252654,"marketCap":345124456},{"date":"2023-04-28","current":-6.132304,"twenty":-20.19724,"median":-5.560857,"eighty":-3.267739,"marketCap":309764542},{"date":"2023-05-05","current":-4.649577,"twenty":-19.866941,"median":-5.533328,"eighty":-3.281552,"marketCap":234866707},{"date":"2023-05-11","current":-4.111377,"twenty":-19.803422,"median":-5.498193,"eighty":-3.28549,"marketCap":210590323},{"date":"2023-05-18","current":-4.945072,"twenty":-19.678198,"median":-5.458607,"eighty":-3.297303,"marketCap":253293360},{"date":"2023-05-26","current":-3.72879,"twenty":-19.513049,"median":-5.429742,"eighty":-3.311742,"marketCap":190993723},{"date":"2023-06-02","current":-5.379051,"twenty":-19.431382,"median":-5.427105,"eighty":-3.316992,"marketCap":275522339},{"date":"2023-06-07","current":-5.281977,"twenty":-19.380567,"median":-5.411414,"eighty":-3.319617,"marketCap":270550068},{"date":"2023-06-15","current":-5.321949,"twenty":-19.337011,"median":-5.419259,"eighty":-3.32093,"marketCap":272597473},{"date":"2023-06-23","current":-6.446867,"twenty":-19.309788,"median":-5.427145,"eighty":-3.32093,"marketCap":330217326},{"date":"2023-06-30","current":-5.470415,"twenty":-19.204528,"median":-5.432339,"eighty":-3.331431,"marketCap":280202124},{"date":"2023-07-07","current":-5.658853,"twenty":-19.043008,"median":-5.458607,"eighty":-3.349234,"marketCap":289854180},{"date":"2023-07-14","current":-5.413313,"twenty":-19.015785,"median":-5.464511,"eighty":-3.358014,"marketCap":277277258},{"date":"2023-07-21","current":-5.83016,"twenty":-18.946824,"median":-5.498966,"eighty":-3.361598,"marketCap":298628777},{"date":"2023-07-28","current":-5.35621,"twenty":-18.834312,"median":-5.502382,"eighty":-3.366756,"marketCap":274352393},{"date":"2023-08-04","current":-5.856075,"twenty":-18.640116,"median":-5.538938,"eighty":-3.368463,"marketCap":299956153},{"date":"2023-08-11","current":-5.640407,"twenty":-18.451374,"median":-5.556069,"eighty":-3.380171,"marketCap":292640150},{"date":"2023-08-18","current":-4.969198,"twenty":-18.244355,"median":-5.538938,"eighty":-3.402313,"marketCap":257815972},{"date":"2023-08-25","current":-5.454273,"twenty":-18.229322,"median":-5.536059,"eighty":-3.424628,"marketCap":282983025},{"date":"2023-09-01","current":-5.082007,"twenty":-18.098783,"median":-5.505799,"eighty":-3.473171,"marketCap":263668775},{"date":"2023-09-08","current":-4.732301,"twenty":-17.576626,"median":-5.490588,"eighty":-3.478329,"marketCap":245525085},{"date":"2023-09-15","current":-4.320552,"twenty":-16.848713,"median":-5.45644,"eighty":-3.500309,"marketCap":224162354},{"date":"2023-09-22","current":-4.360034,"twenty":-15.642603,"median":-5.442993,"eighty":-3.543057,"marketCap":226210835},{"date":"2023-09-29","current":-4.416439,"twenty":-15.41427,"median":-5.427145,"eighty":-3.548423,"marketCap":229137237},{"date":"2023-10-06","current":-4.207743,"twenty":-15.180414,"median":-5.412363,"eighty":-3.550464,"marketCap":218309551},{"date":"2023-10-13","current":-3.522434,"twenty":-14.937351,"median":-5.379051,"eighty":-3.550464,"marketCap":182753773},{"date":"2023-10-20","current":-3.384244,"twenty":-14.860012,"median":-5.35907,"eighty":-3.513584,"marketCap":175584090},{"date":"2023-10-27","current":-3.023258,"twenty":-14.841598,"median":-5.356356,"eighty":-3.478329,"marketCap":156855120},{"date":"2023-11-03","current":-3.384244,"twenty":-14.279974,"median":-5.34622,"eighty":-3.412814,"marketCap":175584090},{"date":"2023-11-10","current":-2.947163,"twenty":-14.252354,"median":-5.321949,"eighty":-3.384244,"marketCap":152172878},{"date":"2023-11-17","current":-2.913665,"twenty":-14.243147,"median":-5.300305,"eighty":-3.384244,"marketCap":150443281},{"date":"2023-11-24","current":-4.364829,"twenty":-13.705461,"median":-5.294869,"eighty":-3.382454,"marketCap":225372231},{"date":"2023-12-01","current":-3.718608,"twenty":-13.129106,"median":-5.237177,"eighty":-3.384244,"marketCap":192005433},{"date":"2023-12-08","current":-4.631254,"twenty":-12.974429,"median":-5.212533,"eighty":-3.384244,"marketCap":239128718},{"date":"2023-12-15","current":-4.381835,"twenty":-12.812387,"median":-5.168731,"eighty":-3.384244,"marketCap":226250305},{"date":"2023-12-22","current":-3.956689,"twenty":-12.49751,"median":-5.15972,"eighty":-3.384244,"marketCap":204298464},{"date":"2023-12-29","current":-4.421515,"twenty":-12.271019,"median":-5.151886,"eighty":-3.384244,"marketCap":228299143},{"date":"2024-01-05","current":-3.837648,"twenty":-12.044528,"median":-5.118331,"eighty":-3.384244,"marketCap":198151949},{"date":"2024-01-12","current":-3.531543,"twenty":-11.586022,"median":-5.092178,"eighty":-3.384244,"marketCap":182346623},{"date":"2024-01-19","current":-3.293462,"twenty":-11.446076,"median":-5.084468,"eighty":-3.384244,"marketCap":170053593},{"date":"2024-01-26","current":-3.514538,"twenty":-11.37242,"median":-5.081696,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-02-02","current":-3.256616,"twenty":-11.315338,"median":-5.051704,"eighty":-3.384244,"marketCap":168151100},{"date":"2024-02-09","current":-3.452183,"twenty":-11.269303,"median":-5.026008,"eighty":-3.380663,"marketCap":178248946},{"date":"2024-02-16","current":-3.797968,"twenty":-11.162502,"median":-4.979499,"eighty":-3.384244,"marketCap":196103110},{"date":"2024-02-23","current":-3.639247,"twenty":-10.897342,"median":-4.964988,"eighty":-3.384244,"marketCap":187907756},{"date":"2024-03-01","current":-3.514538,"twenty":-10.260222,"median":-4.924075,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-03-08","current":-3.658244,"twenty":-9.709646,"median":-4.89778,"eighty":-3.384244,"marketCap":195612256},{"date":"2024-03-15","current":-1.58816,"twenty":-9.573383,"median":-4.876386,"eighty":-3.370913,"marketCap":84921488},{"date":"2024-03-22","current":-1.495061,"twenty":-9.38372,"median":-4.839647,"eighty":-3.363712,"marketCap":79943332},{"date":"2024-03-28","current":-1.330768,"twenty":-9.206947,"median":-4.791108,"eighty":-3.351606,"marketCap":71158350},{"date":"2024-04-05","current":-1.286957,"twenty":-9.206947,"median":-4.774314,"eighty":-3.322939,"marketCap":68815689},{"date":"2024-04-12","current":-1.139094,"twenty":-9.203264,"median":-4.742734,"eighty":-3.314805,"marketCap":60909205},{"date":"2024-04-19","current":-0.969325,"twenty":-9.160911,"median":-4.686056,"eighty":-3.281552,"marketCap":51831391},{"date":"2024-04-26","current":-0.793024,"twenty":-9.045594,"median":-4.679711,"eighty":-3.256999,"marketCap":42404297},{"date":"2024-05-03","current":-0.865117,"twenty":-9.02559,"median":-4.67293,"eighty":-3.222326,"marketCap":46259233},{"date":"2024-05-10","current":-0.853881,"twenty":-9.013601,"median":-4.631996,"eighty":-3.197538,"marketCap":46259233},{"date":"2024-05-17","current":-0.842934,"twenty":-8.960201,"median":-4.600736,"eighty":-3.119794,"marketCap":45666166},{"date":"2024-05-24","current":-0.777251,"twenty":-8.87918,"median":-4.556776,"eighty":-3.079409,"marketCap":42107764},{"date":"2024-05-31","current":-0.755356,"twenty":-8.820255,"median":-4.537707,"eighty":-3.038717,"marketCap":40921629},{"date":"2024-06-07","current":-0.771777,"twenty":-8.746599,"median":-4.512325,"eighty":-2.993026,"marketCap":41811230},{"date":"2024-06-14","current":-0.925038,"twenty":-8.709772,"median":-4.502289,"eighty":-2.980329,"marketCap":50114169},{"date":"2024-06-21","current":-0.771777,"twenty":-8.664307,"median":-4.495207,"eighty":-2.939832,"marketCap":41811230},{"date":"2024-06-28","current":-0.782724,"twenty":-8.640135,"median":-4.489009,"eighty":-2.920581,"marketCap":42404297},{"date":"2024-07-05","current":-0.618516,"twenty":-8.629554,"median":-4.472533,"eighty":-2.895554,"marketCap":33508291},{"date":"2024-07-12","current":-0.717041,"twenty":-8.545779,"median":-4.46206,"eighty":-2.873326,"marketCap":38845895},{"date":"2024-07-15","current":-0.678726,"twenty":-8.525496,"median":-4.461562,"eighty":-2.868076,"marketCap":36770160},{"date":"2024-08-02","current":-0.738935,"twenty":-8.503775,"median":-4.455922,"eighty":-2.850739,"marketCap":40032029},{"date":"2024-08-09","current":-0.592364,"twenty":-8.404824,"median":-4.42544,"eighty":-2.804643,"marketCap":33211757},{"date":"2024-08-16","current":-0.571208,"twenty":-8.326387,"median":-4.418977,"eighty":-2.748595,"marketCap":32025623},{"date":"2024-08-23","current":-0.555341,"twenty":-8.193648,"median":-4.410178,"eighty":-2.718038,"marketCap":31136022},{"date":"2024-08-30","current":-0.61352,"twenty":-8.144091,"median":-4.381439,"eighty":-2.669467,"marketCap":34397891},{"date":"2024-09-06","current":-0.629387,"twenty":-8.138941,"median":-4.377791,"eighty":-2.637596,"marketCap":35287492},{"date":"2024-09-13","current":-0.756322,"twenty":-8.109177,"median":-4.364829,"eighty":-2.553047,"marketCap":42404297},{"date":"2024-09-20","current":-1.27993,"twenty":-8.065285,"median":-4.359401,"eighty":-2.472746,"marketCap":71761119},{"date":"2024-09-27","current":-1.38042,"twenty":-8.006605,"median":-4.328077,"eighty":-2.428786,"marketCap":77395256},{"date":"2024-10-04","current":-1.253485,"twenty":-7.946269,"median":-4.308243,"eighty":-2.401311,"marketCap":70278451},{"date":"2024-10-11","current":-1.17415,"twenty":-7.940236,"median":-4.278792,"eighty":-2.379331,"marketCap":65830448},{"date":"2024-10-18","current":-1.105394,"twenty":-7.928168,"median":-4.243224,"eighty":-2.324381,"marketCap":61975511},{"date":"2024-10-25","current":-1.137127,"twenty":-7.922135,"median":-4.223408,"eighty":-2.296906,"marketCap":63754713},{"date":"2024-10-31","current":-1.015481,"twenty":-7.922135,"median":-4.220076,"eighty":-2.247451,"marketCap":56934441},{"date":"2024-11-08","current":-1.02077,"twenty":-7.917308,"median":-4.210694,"eighty":-2.203491,"marketCap":57230975},{"date":"2024-11-15","current":-0.990682,"twenty":-7.877486,"median":-4.200386,"eighty":-2.163927,"marketCap":57527508},{"date":"2024-11-22","current":-1.077494,"twenty":-7.863006,"median":-4.18227,"eighty":-2.124364,"marketCap":62568579},{"date":"2024-11-29","current":-1.117565,"twenty":-7.850938,"median":-4.154565,"eighty":-1.653919,"marketCap":64895436},{"date":"2024-12-06","current":-1.144301,"twenty":-7.836458,"median":-4.134218,"eighty":-1.535604,"marketCap":66447958},{"date":"2024-12-13","current":-1.053398,"twenty":-7.828011,"median":-4.114285,"eighty":-1.501633,"marketCap":61169382},{"date":"2024-12-20","current":-0.983885,"twenty":-7.785775,"median":-4.110253,"eighty":-1.404904,"marketCap":57132824},{"date":"2024-12-27","current":-1.16569,"twenty":-7.756814,"median":-4.094935,"eighty":-1.382465,"marketCap":67689976},{"date":"2025-01-03","current":-1.181731,"twenty":-7.753194,"median":-4.069124,"eighty":-1.319715,"marketCap":68621490},{"date":"2025-01-10","current":-1.06944,"twenty":-7.753194,"median":-4.066404,"eighty":-1.306374,"marketCap":62100896},{"date":"2025-01-17","current":-1.048051,"twenty":-7.710958,"median":-4.027437,"eighty":-1.27993,"marketCap":60858878},{"date":"2025-01-24","current":-1.149648,"twenty":-7.677701,"median":-4.004689,"eighty":-1.260248,"marketCap":66758463},{"date":"2025-01-31","current":-1.037357,"twenty":-7.649549,"median":-3.985032,"eighty":-1.226534,"marketCap":60237869},{"date":"2025-02-07","current":-1.064093,"twenty":-7.561309,"median":-3.979207,"eighty":-1.20312,"marketCap":61790391},{"date":"2025-02-14","current":-0.994579,"twenty":-7.536885,"median":-3.968026,"eighty":-1.196414,"marketCap":57753833},{"date":"2025-02-21","current":-0.914371,"twenty":-7.521503,"median":-3.9572,"eighty":-1.17549,"marketCap":53096266},{"date":"2025-02-28","current":-0.892982,"twenty":-7.492892,"median":-3.932768,"eighty":-1.164843,"marketCap":51854248},{"date":"2025-03-07","current":-0.807427,"twenty":-7.444909,"median":-3.863096,"eighty":-1.158283,"marketCap":46886176},{"date":"2025-03-14","current":-0.823469,"twenty":-7.414105,"median":-3.842071,"eighty":-1.144301,"marketCap":47817689},{"date":"2025-03-21","current":-0.882288,"twenty":-7.351355,"median":-3.83198,"eighty":-1.141087,"marketCap":51233239},{"date":"2025-03-28","current":-0.976018,"twenty":-7.269298,"median":-3.811457,"eighty":-1.130407,"marketCap":59572838},{"date":"2025-04-04","current":-0.887824,"twenty":-7.236716,"median":-3.801177,"eighty":-1.115426,"marketCap":54189750},{"date":"2025-04-11","current":-0.729074,"twenty":-7.230193,"median":-3.789261,"eighty":-1.103846,"marketCap":44500192},{"date":"2025-04-17","current":-0.734953,"twenty":-7.179577,"median":-3.774363,"eighty":-1.086551,"marketCap":44859065},{"date":"2025-04-25","current":-0.858426,"twenty":-7.067737,"median":-3.746951,"eighty":-1.070619,"marketCap":52395387},{"date":"2025-05-02","current":-0.758472,"twenty":-6.968014,"median":-3.738989,"eighty":-1.063486,"marketCap":46294555},{"date":"2025-05-09","current":-0.691313,"twenty":-6.896128,"median":-3.72879,"eighty":-1.048324,"marketCap":42705829},{"date":"2025-05-16","current":-0.74855,"twenty":-6.859478,"median":-3.718608,"eighty":-1.042704,"marketCap":46241627},{"date":"2025-05-23","current":-0.844668,"twenty":-6.802547,"median":-3.708154,"eighty":-1.037357,"marketCap":52179267},{"date":"2025-05-30","current":-0.987387,"twenty":-6.754216,"median":-3.695933,"eighty":-1.028657,"marketCap":60995764},{"date":"2025-06-05","current":-1.141758,"twenty":-6.739485,"median":-3.678927,"eighty":-1.026662,"marketCap":70531975}],"updateTime":1749281883381}}}